Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fatty Acid-Binding Proteins | 28 | 2019 | 295 | 3.820 |
Why?
|
Adipocytes | 31 | 2008 | 1187 | 2.850 |
Why?
|
Insulin Resistance | 40 | 2019 | 3954 | 1.970 |
Why?
|
Endoplasmic Reticulum | 11 | 2010 | 1132 | 1.670 |
Why?
|
Obesity | 58 | 2015 | 12933 | 1.650 |
Why?
|
Adipose Tissue | 40 | 2009 | 3309 | 1.550 |
Why?
|
Tumor Necrosis Factor-alpha | 31 | 2009 | 4341 | 1.530 |
Why?
|
Receptors, Tumor Necrosis Factor | 18 | 2003 | 581 | 1.190 |
Why?
|
Metabolic Diseases | 5 | 2017 | 680 | 1.150 |
Why?
|
Inflammation | 23 | 2017 | 10760 | 0.960 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 6 | 2008 | 438 | 0.940 |
Why?
|
Carrier Proteins | 13 | 2005 | 4935 | 0.800 |
Why?
|
Insulin | 28 | 2013 | 6593 | 0.780 |
Why?
|
Lipid Metabolism | 16 | 2015 | 1896 | 0.730 |
Why?
|
Stress, Physiological | 8 | 2010 | 1403 | 0.700 |
Why?
|
Propionates | 1 | 2019 | 183 | 0.620 |
Why?
|
Glucose | 16 | 2017 | 4345 | 0.600 |
Why?
|
Macrophages | 15 | 2015 | 5758 | 0.570 |
Why?
|
Neoplasm Proteins | 11 | 2015 | 3607 | 0.570 |
Why?
|
Glucagon | 1 | 2019 | 531 | 0.560 |
Why?
|
Diabetes Mellitus, Type 2 | 16 | 2013 | 12142 | 0.530 |
Why?
|
Mitogen-Activated Protein Kinase 8 | 5 | 2008 | 71 | 0.530 |
Why?
|
Leptin | 14 | 2015 | 1595 | 0.520 |
Why?
|
Myelin P2 Protein | 3 | 2000 | 20 | 0.500 |
Why?
|
Animals | 88 | 2019 | 168201 | 0.480 |
Why?
|
Arteriosclerosis | 6 | 2005 | 1056 | 0.480 |
Why?
|
Mice | 65 | 2019 | 81368 | 0.450 |
Why?
|
Receptor, Insulin | 11 | 2008 | 836 | 0.450 |
Why?
|
Proteins | 12 | 2008 | 6030 | 0.420 |
Why?
|
GATA3 Transcription Factor | 4 | 2007 | 154 | 0.420 |
Why?
|
Adiponectin | 6 | 2006 | 1107 | 0.420 |
Why?
|
Phenylbutyrates | 3 | 2008 | 72 | 0.410 |
Why?
|
Hormones, Ectopic | 2 | 2003 | 37 | 0.400 |
Why?
|
Cell Differentiation | 10 | 2007 | 11514 | 0.400 |
Why?
|
GATA2 Transcription Factor | 4 | 2005 | 158 | 0.400 |
Why?
|
Mice, Obese | 11 | 2015 | 418 | 0.400 |
Why?
|
Diabetes Mellitus | 10 | 2015 | 5835 | 0.390 |
Why?
|
Fatty Acids, Monounsaturated | 2 | 2013 | 190 | 0.390 |
Why?
|
Liver | 11 | 2013 | 7512 | 0.380 |
Why?
|
Immunity | 1 | 2017 | 994 | 0.380 |
Why?
|
Energy Metabolism | 3 | 2019 | 2878 | 0.380 |
Why?
|
Unfolded Protein Response | 2 | 2010 | 234 | 0.370 |
Why?
|
Thiazolidinediones | 3 | 2009 | 460 | 0.350 |
Why?
|
Atherosclerosis | 6 | 2013 | 3400 | 0.340 |
Why?
|
Taurochenodeoxycholic Acid | 2 | 2007 | 35 | 0.340 |
Why?
|
Mitogen-Activated Protein Kinase 9 | 2 | 2006 | 29 | 0.330 |
Why?
|
Trans-Activators | 3 | 2005 | 2852 | 0.330 |
Why?
|
Overnutrition | 1 | 2008 | 25 | 0.320 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 12 | 2006 | 254 | 0.320 |
Why?
|
Adipose Tissue, Brown | 3 | 2005 | 762 | 0.310 |
Why?
|
Mice, Inbred C57BL | 25 | 2019 | 22115 | 0.300 |
Why?
|
Nerve Tissue Proteins | 5 | 2002 | 4408 | 0.300 |
Why?
|
CCAAT-Enhancer-Binding Protein-alpha | 2 | 2006 | 130 | 0.300 |
Why?
|
Antigens, CD | 10 | 2003 | 3998 | 0.290 |
Why?
|
Homeostasis | 12 | 2008 | 3321 | 0.280 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2013 | 1320 | 0.270 |
Why?
|
Mice, Knockout | 19 | 2015 | 14389 | 0.270 |
Why?
|
Fatty Acids | 6 | 2006 | 1808 | 0.260 |
Why?
|
Adipogenesis | 2 | 2006 | 366 | 0.260 |
Why?
|
Intercellular Signaling Peptides and Proteins | 5 | 2005 | 1650 | 0.260 |
Why?
|
Transcription Factors | 7 | 2008 | 12116 | 0.260 |
Why?
|
Signal Transduction | 18 | 2017 | 23416 | 0.250 |
Why?
|
Mammary Glands, Human | 1 | 2007 | 202 | 0.250 |
Why?
|
Cholesterol | 5 | 2007 | 2903 | 0.250 |
Why?
|
Mammary Glands, Animal | 1 | 2007 | 272 | 0.250 |
Why?
|
PPAR gamma | 2 | 2005 | 484 | 0.240 |
Why?
|
Hormones | 1 | 2008 | 869 | 0.230 |
Why?
|
Lipolysis | 3 | 2000 | 211 | 0.230 |
Why?
|
Mitogen-Activated Protein Kinases | 3 | 2004 | 1242 | 0.230 |
Why?
|
DNA-Binding Proteins | 5 | 2005 | 9586 | 0.230 |
Why?
|
Gene Expression Regulation | 12 | 2012 | 11874 | 0.230 |
Why?
|
Apoptosis | 6 | 2012 | 9476 | 0.230 |
Why?
|
Triglycerides | 8 | 2013 | 2459 | 0.220 |
Why?
|
Cell Lineage | 3 | 2015 | 2554 | 0.220 |
Why?
|
Glucose Tolerance Test | 6 | 2006 | 1178 | 0.220 |
Why?
|
Tumor Suppressor Proteins | 4 | 2008 | 2801 | 0.220 |
Why?
|
Hypothalamus | 1 | 2008 | 999 | 0.210 |
Why?
|
Blood Glucose | 8 | 2008 | 6390 | 0.210 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 3 | 2005 | 858 | 0.210 |
Why?
|
Hypertriglyceridemia | 1 | 2006 | 293 | 0.210 |
Why?
|
Food | 2 | 2007 | 768 | 0.210 |
Why?
|
Insulin Receptor Substrate Proteins | 6 | 2008 | 557 | 0.210 |
Why?
|
Metabolic Networks and Pathways | 1 | 2007 | 789 | 0.210 |
Why?
|
Gene Expression | 6 | 2006 | 7568 | 0.200 |
Why?
|
Apolipoproteins E | 5 | 2007 | 1443 | 0.200 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 8 | 2006 | 344 | 0.190 |
Why?
|
Mice, Transgenic | 11 | 2009 | 9529 | 0.190 |
Why?
|
eIF-2 Kinase | 3 | 2008 | 145 | 0.190 |
Why?
|
Cytokines | 4 | 2017 | 7373 | 0.190 |
Why?
|
Cell Line | 11 | 2008 | 15576 | 0.190 |
Why?
|
Protein Folding | 3 | 2010 | 870 | 0.180 |
Why?
|
Fatty Liver | 1 | 2006 | 787 | 0.170 |
Why?
|
Organ Specificity | 3 | 2017 | 1964 | 0.170 |
Why?
|
Phosphorylation | 9 | 2006 | 8311 | 0.170 |
Why?
|
Membrane Proteins | 4 | 2007 | 7847 | 0.170 |
Why?
|
Blotting, Northern | 5 | 2005 | 1545 | 0.170 |
Why?
|
Lipids | 8 | 2013 | 3332 | 0.170 |
Why?
|
RNA, Messenger | 15 | 2009 | 12758 | 0.170 |
Why?
|
Glycogen | 1 | 2019 | 251 | 0.160 |
Why?
|
Mice, Mutant Strains | 4 | 2007 | 1748 | 0.150 |
Why?
|
Interleukin-6 | 7 | 2007 | 3206 | 0.140 |
Why?
|
Phosphoproteins | 5 | 2004 | 2446 | 0.140 |
Why?
|
Neovascularization, Physiologic | 2 | 2015 | 1349 | 0.140 |
Why?
|
Stearoyl-CoA Desaturase | 2 | 2008 | 85 | 0.140 |
Why?
|
Humans | 61 | 2019 | 760617 | 0.130 |
Why?
|
Cells, Cultured | 9 | 2012 | 18937 | 0.130 |
Why?
|
Biological Evolution | 2 | 2017 | 1070 | 0.130 |
Why?
|
Cell Communication | 2 | 2017 | 1654 | 0.130 |
Why?
|
3T3 Cells | 6 | 2006 | 1085 | 0.130 |
Why?
|
Adenylate Kinase | 2 | 2006 | 102 | 0.130 |
Why?
|
Body Composition | 2 | 2003 | 2426 | 0.130 |
Why?
|
Body Weight | 6 | 2006 | 4614 | 0.130 |
Why?
|
Promoter Regions, Genetic | 5 | 2006 | 5780 | 0.130 |
Why?
|
Receptors, Adrenergic, beta | 3 | 2001 | 242 | 0.130 |
Why?
|
I-kappa B Kinase | 2 | 2008 | 249 | 0.130 |
Why?
|
Polymorphism, Genetic | 1 | 2006 | 4242 | 0.130 |
Why?
|
Mast Cells | 2 | 2015 | 1392 | 0.130 |
Why?
|
Hypercholesterolemia | 1 | 2002 | 1141 | 0.130 |
Why?
|
Plasminogen Activator Inhibitor 1 | 3 | 2003 | 277 | 0.120 |
Why?
|
Cryoprotective Agents | 1 | 1996 | 128 | 0.120 |
Why?
|
Ethylene Glycols | 1 | 1996 | 190 | 0.120 |
Why?
|
Epithelial Cells | 1 | 2007 | 3672 | 0.120 |
Why?
|
Cell Membrane | 3 | 2002 | 3680 | 0.120 |
Why?
|
Organ Size | 3 | 2004 | 2252 | 0.110 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 4 | 2006 | 4570 | 0.110 |
Why?
|
Models, Biological | 5 | 2008 | 9461 | 0.110 |
Why?
|
Adaptive Immunity | 1 | 2017 | 724 | 0.100 |
Why?
|
Weight Gain | 2 | 2019 | 2350 | 0.100 |
Why?
|
Muscle Proteins | 1 | 1997 | 1152 | 0.100 |
Why?
|
Immune System | 1 | 2017 | 791 | 0.100 |
Why?
|
Stem Cell Factor | 1 | 2012 | 195 | 0.100 |
Why?
|
Bone Marrow Transplantation | 3 | 2008 | 2690 | 0.100 |
Why?
|
Resistin | 2 | 2003 | 172 | 0.090 |
Why?
|
Oocytes | 1 | 1996 | 1166 | 0.090 |
Why?
|
Cytoskeleton | 1 | 1996 | 1170 | 0.090 |
Why?
|
Cryopreservation | 1 | 1996 | 728 | 0.090 |
Why?
|
Nerve Growth Factor | 2 | 2003 | 158 | 0.090 |
Why?
|
Male | 39 | 2019 | 360358 | 0.090 |
Why?
|
Thinness | 3 | 2006 | 480 | 0.090 |
Why?
|
Aorta | 4 | 2015 | 2041 | 0.090 |
Why?
|
Inflammation Mediators | 2 | 2017 | 1884 | 0.090 |
Why?
|
Immunoblotting | 2 | 2005 | 1646 | 0.090 |
Why?
|
Dietary Fats | 3 | 2013 | 1995 | 0.090 |
Why?
|
Receptors, Adrenergic, beta-3 | 2 | 2000 | 62 | 0.090 |
Why?
|
Blotting, Western | 6 | 2012 | 5034 | 0.090 |
Why?
|
Muscle, Skeletal | 5 | 2008 | 4947 | 0.090 |
Why?
|
Multiprotein Complexes | 2 | 2008 | 1118 | 0.090 |
Why?
|
Protein Isoforms | 2 | 2006 | 1697 | 0.080 |
Why?
|
Chemokine CXCL5 | 1 | 2009 | 27 | 0.080 |
Why?
|
Dairy Products | 1 | 2013 | 490 | 0.080 |
Why?
|
Genes, Reporter | 2 | 2005 | 1525 | 0.080 |
Why?
|
Retinopathy of Prematurity | 1 | 2014 | 439 | 0.080 |
Why?
|
Cromolyn Sodium | 1 | 2009 | 78 | 0.080 |
Why?
|
Rats | 5 | 2005 | 23717 | 0.080 |
Why?
|
HIV-1 | 1 | 2006 | 6858 | 0.080 |
Why?
|
Diet | 7 | 2013 | 8048 | 0.070 |
Why?
|
Transcription, Genetic | 5 | 2006 | 7583 | 0.070 |
Why?
|
Ligands | 2 | 2008 | 3268 | 0.070 |
Why?
|
Hyperinsulinism | 3 | 2008 | 400 | 0.070 |
Why?
|
Body Fat Distribution | 1 | 2008 | 245 | 0.070 |
Why?
|
Mutation | 8 | 2007 | 30016 | 0.070 |
Why?
|
3T3-L1 Cells | 1 | 2007 | 209 | 0.070 |
Why?
|
Lipogenesis | 1 | 2008 | 214 | 0.070 |
Why?
|
C-Reactive Protein | 4 | 2007 | 3822 | 0.070 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 1 | 2007 | 164 | 0.070 |
Why?
|
Female | 26 | 2019 | 392148 | 0.060 |
Why?
|
Chemokine CCL2 | 1 | 2008 | 602 | 0.060 |
Why?
|
Receptors, HIV | 1 | 2006 | 158 | 0.060 |
Why?
|
Multiple Birth Offspring | 1 | 2005 | 22 | 0.060 |
Why?
|
Eukaryotic Initiation Factor-2 | 1 | 2006 | 181 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2009 | 727 | 0.060 |
Why?
|
Immunity, Innate | 1 | 2017 | 3045 | 0.060 |
Why?
|
HIV-Associated Lipodystrophy Syndrome | 1 | 2006 | 138 | 0.060 |
Why?
|
Orphan Nuclear Receptors | 1 | 2005 | 63 | 0.060 |
Why?
|
Tunicamycin | 1 | 2004 | 108 | 0.060 |
Why?
|
NF-kappa B | 2 | 2005 | 2481 | 0.060 |
Why?
|
Recombinant Fusion Proteins | 2 | 2005 | 3730 | 0.060 |
Why?
|
CCAAT-Enhancer-Binding Protein-beta | 1 | 2005 | 102 | 0.060 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2006 | 457 | 0.060 |
Why?
|
Mitochondrial Proteins | 2 | 2000 | 974 | 0.060 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2005 | 318 | 0.060 |
Why?
|
Body Mass Index | 9 | 2005 | 12943 | 0.060 |
Why?
|
Mesentery | 1 | 2004 | 202 | 0.060 |
Why?
|
Luciferases | 1 | 2005 | 712 | 0.060 |
Why?
|
Reference Values | 4 | 2003 | 4919 | 0.050 |
Why?
|
Genes, Tumor Suppressor | 1 | 2008 | 1056 | 0.050 |
Why?
|
Tissue Distribution | 2 | 2005 | 2261 | 0.050 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2005 | 517 | 0.050 |
Why?
|
Protein Binding | 2 | 2006 | 9345 | 0.050 |
Why?
|
CD40 Ligand | 1 | 2005 | 521 | 0.050 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2009 | 1117 | 0.050 |
Why?
|
Mice, Congenic | 1 | 2002 | 97 | 0.050 |
Why?
|
Cardiovascular Diseases | 2 | 2006 | 15498 | 0.050 |
Why?
|
Immunosorbent Techniques | 1 | 2002 | 174 | 0.050 |
Why?
|
Cyclooxygenase 2 | 1 | 2005 | 596 | 0.050 |
Why?
|
Phenotype | 3 | 2006 | 16571 | 0.050 |
Why?
|
Endothelium, Vascular | 2 | 2012 | 4433 | 0.050 |
Why?
|
Biphenyl Compounds | 1 | 2007 | 1007 | 0.050 |
Why?
|
Enzyme Activation | 2 | 2006 | 3591 | 0.050 |
Why?
|
CHO Cells | 1 | 2005 | 1387 | 0.050 |
Why?
|
Base Sequence | 2 | 2006 | 12421 | 0.050 |
Why?
|
Microscopy, Electron | 1 | 2005 | 2561 | 0.050 |
Why?
|
Diet, Fat-Restricted | 1 | 2004 | 329 | 0.050 |
Why?
|
Tyrosine | 3 | 2001 | 1440 | 0.050 |
Why?
|
Nitric Oxide Synthase | 1 | 2005 | 908 | 0.050 |
Why?
|
Premenopause | 2 | 1997 | 1038 | 0.050 |
Why?
|
Crosses, Genetic | 1 | 2003 | 750 | 0.050 |
Why?
|
Blood Specimen Collection | 1 | 2003 | 238 | 0.050 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2007 | 823 | 0.050 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2006 | 1169 | 0.050 |
Why?
|
Isoenzymes | 1 | 2006 | 1687 | 0.050 |
Why?
|
Blotting, Southern | 1 | 2002 | 777 | 0.050 |
Why?
|
Multienzyme Complexes | 1 | 2005 | 666 | 0.050 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2007 | 974 | 0.050 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2005 | 597 | 0.050 |
Why?
|
Precipitin Tests | 1 | 2002 | 813 | 0.050 |
Why?
|
Disease Models, Animal | 4 | 2006 | 18221 | 0.050 |
Why?
|
Benzophenones | 1 | 2001 | 57 | 0.050 |
Why?
|
Indicators and Reagents | 1 | 2002 | 460 | 0.050 |
Why?
|
Cricetinae | 1 | 2005 | 2424 | 0.050 |
Why?
|
Myeloid Cells | 1 | 2006 | 823 | 0.050 |
Why?
|
Chemotaxis | 2 | 2015 | 598 | 0.050 |
Why?
|
Protein Biosynthesis | 2 | 1999 | 2100 | 0.050 |
Why?
|
Sirolimus | 1 | 2008 | 1533 | 0.050 |
Why?
|
Cell Adhesion Molecules | 1 | 2007 | 1602 | 0.050 |
Why?
|
Uncoupling Agents | 1 | 2000 | 46 | 0.050 |
Why?
|
Haptoglobins | 1 | 2002 | 165 | 0.050 |
Why?
|
ADAM Proteins | 1 | 2002 | 238 | 0.040 |
Why?
|
Reproductive Techniques, Assisted | 1 | 2005 | 496 | 0.040 |
Why?
|
Hepatocytes | 1 | 2007 | 1231 | 0.040 |
Why?
|
Metalloendopeptidases | 1 | 2002 | 393 | 0.040 |
Why?
|
HIV Infections | 2 | 2006 | 17337 | 0.040 |
Why?
|
Nutritional Status | 1 | 2008 | 1596 | 0.040 |
Why?
|
Biological Transport | 1 | 2005 | 2089 | 0.040 |
Why?
|
Gastric Bypass | 1 | 2008 | 818 | 0.040 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2003 | 540 | 0.040 |
Why?
|
Genetic Markers | 1 | 2006 | 2601 | 0.040 |
Why?
|
Hypoglycemic Agents | 2 | 2004 | 3085 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2008 | 2456 | 0.040 |
Why?
|
Eating | 2 | 2006 | 1535 | 0.040 |
Why?
|
Binding Sites | 1 | 2008 | 6051 | 0.040 |
Why?
|
Hyperlipoproteinemia Type II | 1 | 2004 | 395 | 0.040 |
Why?
|
Cell Line, Tumor | 2 | 2006 | 16967 | 0.040 |
Why?
|
Drug Interactions | 1 | 2004 | 1415 | 0.040 |
Why?
|
Interleukin-2 | 1 | 2006 | 1887 | 0.040 |
Why?
|
In Situ Nick-End Labeling | 1 | 2000 | 613 | 0.040 |
Why?
|
Leukocytes, Mononuclear | 1 | 2006 | 1835 | 0.040 |
Why?
|
Lymphocyte Activation | 2 | 2007 | 5463 | 0.040 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2008 | 2057 | 0.040 |
Why?
|
Dendritic Cells | 2 | 2007 | 2722 | 0.040 |
Why?
|
Oxygen | 2 | 2014 | 4226 | 0.040 |
Why?
|
Ion Channels | 2 | 2000 | 1039 | 0.040 |
Why?
|
Vascular Diseases | 1 | 2007 | 1160 | 0.040 |
Why?
|
Social Behavior | 1 | 2005 | 1135 | 0.040 |
Why?
|
Lipoproteins, HDL | 1 | 2003 | 675 | 0.040 |
Why?
|
Life Style | 4 | 2005 | 3904 | 0.040 |
Why?
|
Zinc Fingers | 1 | 2000 | 578 | 0.040 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2001 | 1692 | 0.040 |
Why?
|
Up-Regulation | 3 | 2002 | 4117 | 0.040 |
Why?
|
Models, Molecular | 1 | 2008 | 5433 | 0.040 |
Why?
|
Asthma | 2 | 2007 | 6233 | 0.040 |
Why?
|
Neurons | 2 | 2008 | 9438 | 0.040 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2006 | 1894 | 0.040 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2008 | 2895 | 0.040 |
Why?
|
Cloning, Molecular | 1 | 2003 | 4172 | 0.040 |
Why?
|
Glucose Transporter Type 4 | 1 | 1997 | 240 | 0.040 |
Why?
|
Time Factors | 5 | 2006 | 39913 | 0.040 |
Why?
|
Blood Pressure | 1 | 2013 | 8472 | 0.040 |
Why?
|
Hypersensitivity | 1 | 2006 | 1167 | 0.030 |
Why?
|
Body Temperature | 1 | 2000 | 780 | 0.030 |
Why?
|
Absorptiometry, Photon | 1 | 2003 | 1738 | 0.030 |
Why?
|
Actins | 3 | 2002 | 2050 | 0.030 |
Why?
|
Odds Ratio | 2 | 2006 | 9643 | 0.030 |
Why?
|
Oxidative Stress | 1 | 2008 | 3113 | 0.030 |
Why?
|
Molecular Sequence Data | 2 | 2007 | 17629 | 0.030 |
Why?
|
Longevity | 1 | 2004 | 1064 | 0.030 |
Why?
|
Pyrazoles | 1 | 2007 | 2008 | 0.030 |
Why?
|
Ethylene Glycol | 1 | 1996 | 31 | 0.030 |
Why?
|
Cold Temperature | 1 | 2000 | 784 | 0.030 |
Why?
|
Regression Analysis | 2 | 1997 | 6338 | 0.030 |
Why?
|
Cyclic AMP | 1 | 2000 | 1463 | 0.030 |
Why?
|
Kinetics | 1 | 2004 | 6370 | 0.030 |
Why?
|
Rats, Zucker | 1 | 1996 | 131 | 0.030 |
Why?
|
Sphingomyelin Phosphodiesterase | 1 | 1996 | 82 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2001 | 3074 | 0.030 |
Why?
|
Monosaccharide Transport Proteins | 1 | 1997 | 436 | 0.030 |
Why?
|
Middle Aged | 17 | 2013 | 220584 | 0.030 |
Why?
|
PPAR delta | 1 | 2015 | 40 | 0.030 |
Why?
|
Prospective Studies | 8 | 2013 | 54360 | 0.030 |
Why?
|
Mice, Inbred BALB C | 1 | 2004 | 6188 | 0.030 |
Why?
|
Exercise | 2 | 2003 | 5886 | 0.030 |
Why?
|
Feces | 1 | 2002 | 1490 | 0.030 |
Why?
|
Cytoprotection | 1 | 2015 | 200 | 0.030 |
Why?
|
DNA Primers | 1 | 1999 | 2817 | 0.030 |
Why?
|
Gene Deletion | 1 | 2002 | 2661 | 0.030 |
Why?
|
Models, Genetic | 1 | 2005 | 3431 | 0.030 |
Why?
|
Protein Structure, Tertiary | 1 | 2001 | 3792 | 0.030 |
Why?
|
Myocardial Ischemia | 1 | 2005 | 2110 | 0.030 |
Why?
|
Membrane Transport Proteins | 1 | 2000 | 1034 | 0.030 |
Why?
|
Islets of Langerhans | 1 | 2000 | 1340 | 0.030 |
Why?
|
Cell Survival | 2 | 2015 | 5780 | 0.030 |
Why?
|
Adult | 14 | 2006 | 220969 | 0.030 |
Why?
|
Interleukin-12 | 2 | 2006 | 577 | 0.030 |
Why?
|
Down-Regulation | 1 | 2001 | 2915 | 0.030 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2003 | 1390 | 0.030 |
Why?
|
Thiazoles | 1 | 2001 | 1517 | 0.030 |
Why?
|
Pancreas | 1 | 2000 | 1690 | 0.030 |
Why?
|
Hydrogenation | 1 | 2013 | 20 | 0.030 |
Why?
|
Adaptation, Physiological | 1 | 2000 | 1300 | 0.030 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2006 | 4366 | 0.030 |
Why?
|
Gene Targeting | 1 | 1996 | 837 | 0.030 |
Why?
|
Cohort Studies | 5 | 2007 | 41457 | 0.030 |
Why?
|
Disease Progression | 2 | 2007 | 13495 | 0.030 |
Why?
|
T-Lymphocytes | 2 | 2007 | 10175 | 0.030 |
Why?
|
Serine | 1 | 1996 | 830 | 0.020 |
Why?
|
Trans Fatty Acids | 1 | 2013 | 155 | 0.020 |
Why?
|
Genotype | 1 | 2006 | 12978 | 0.020 |
Why?
|
Feeding Behavior | 1 | 2003 | 3182 | 0.020 |
Why?
|
Weight Loss | 1 | 2002 | 2682 | 0.020 |
Why?
|
DNA | 1 | 2005 | 7196 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2001 | 2985 | 0.020 |
Why?
|
Cell Death | 1 | 2015 | 1677 | 0.020 |
Why?
|
C-Peptide | 2 | 2003 | 440 | 0.020 |
Why?
|
Interleukin-1 | 2 | 2006 | 1248 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2000 | 2637 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2004 | 5789 | 0.020 |
Why?
|
Diet, Atherogenic | 1 | 2009 | 92 | 0.020 |
Why?
|
Receptors, Leptin | 2 | 2001 | 350 | 0.020 |
Why?
|
Radioimmunoassay | 2 | 2001 | 861 | 0.020 |
Why?
|
Case-Control Studies | 5 | 2007 | 22148 | 0.020 |
Why?
|
Phospholipids | 1 | 2013 | 786 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 1996 | 2639 | 0.020 |
Why?
|
Glucose Clamp Technique | 1 | 2008 | 262 | 0.020 |
Why?
|
Fluorescent Dyes | 1 | 1996 | 1901 | 0.020 |
Why?
|
Retinal Vessels | 1 | 2014 | 852 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 1997 | 6520 | 0.020 |
Why?
|
Anthropometry | 2 | 2004 | 1338 | 0.020 |
Why?
|
Stem Cells | 1 | 2000 | 3516 | 0.020 |
Why?
|
Thrombosis | 1 | 2001 | 2943 | 0.020 |
Why?
|
Lymphocyte Culture Test, Mixed | 1 | 2006 | 508 | 0.020 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2006 | 96 | 0.020 |
Why?
|
I-kappa B Proteins | 1 | 2006 | 211 | 0.020 |
Why?
|
Injections, Intraperitoneal | 1 | 2006 | 412 | 0.020 |
Why?
|
Child, Preschool | 1 | 2008 | 42188 | 0.020 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2006 | 328 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2008 | 13635 | 0.020 |
Why?
|
E-Selectin | 1 | 2007 | 577 | 0.010 |
Why?
|
Cross-Sectional Studies | 5 | 2005 | 26049 | 0.010 |
Why?
|
Aging | 2 | 2001 | 8699 | 0.010 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2007 | 691 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2006 | 17878 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2009 | 1333 | 0.010 |
Why?
|
Risk Factors | 6 | 2013 | 74115 | 0.010 |
Why?
|
Follow-Up Studies | 4 | 2008 | 39063 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 2014 | 2644 | 0.010 |
Why?
|
Immunoprecipitation | 1 | 2006 | 876 | 0.010 |
Why?
|
Adoptive Transfer | 1 | 2006 | 818 | 0.010 |
Why?
|
RNA Interference | 1 | 2012 | 2830 | 0.010 |
Why?
|
Cholesterol, LDL | 1 | 2013 | 2379 | 0.010 |
Why?
|
Quality of Life | 1 | 2005 | 13347 | 0.010 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2007 | 1128 | 0.010 |
Why?
|
Psychology | 1 | 2005 | 356 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2004 | 11459 | 0.010 |
Why?
|
Respiratory Mucosa | 1 | 2006 | 438 | 0.010 |
Why?
|
Aged | 8 | 2013 | 169042 | 0.010 |
Why?
|
Interleukin-4 | 1 | 2006 | 1146 | 0.010 |
Why?
|
Bronchi | 1 | 2006 | 846 | 0.010 |
Why?
|
Clenbuterol | 1 | 2001 | 9 | 0.010 |
Why?
|
Organic Anion Transporters | 1 | 2002 | 101 | 0.010 |
Why?
|
Fatty Acids, Omega-6 | 1 | 2003 | 225 | 0.010 |
Why?
|
Antigen Presentation | 1 | 2007 | 1250 | 0.010 |
Why?
|
Dobutamine | 1 | 2001 | 116 | 0.010 |
Why?
|
Dioxoles | 1 | 2001 | 95 | 0.010 |
Why?
|
Isoproterenol | 1 | 2001 | 397 | 0.010 |
Why?
|
Cholesterol Esters | 1 | 2001 | 73 | 0.010 |
Why?
|
Eicosanoids | 1 | 2003 | 282 | 0.010 |
Why?
|
Foam Cells | 1 | 2001 | 68 | 0.010 |
Why?
|
Protein Kinase C | 1 | 2006 | 1202 | 0.010 |
Why?
|
Adrenergic alpha-Agonists | 1 | 2001 | 177 | 0.010 |
Why?
|
Th2 Cells | 1 | 2006 | 1056 | 0.010 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2001 | 178 | 0.010 |
Why?
|
Oxidation-Reduction | 1 | 2006 | 2231 | 0.010 |
Why?
|
Adrenergic beta-Agonists | 1 | 2001 | 346 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2006 | 1670 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2015 | 10432 | 0.010 |
Why?
|
Food Deprivation | 1 | 2000 | 114 | 0.010 |
Why?
|
COS Cells | 1 | 2001 | 1130 | 0.010 |
Why?
|
Multivariate Analysis | 2 | 2005 | 12043 | 0.010 |
Why?
|
Solubility | 1 | 2001 | 1089 | 0.010 |
Why?
|
Glycoproteins | 1 | 2007 | 2200 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2007 | 20988 | 0.010 |
Why?
|
Hyperphagia | 1 | 2000 | 139 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2005 | 2925 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2012 | 3548 | 0.010 |
Why?
|
Menopause | 1 | 2007 | 1645 | 0.010 |
Why?
|
Bone Marrow Cells | 1 | 2006 | 2409 | 0.010 |
Why?
|
Spinal Cord | 1 | 2007 | 1807 | 0.010 |
Why?
|
Norepinephrine | 1 | 2001 | 898 | 0.010 |
Why?
|
Neoplasms | 1 | 2008 | 22131 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 2006 | 1662 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2006 | 4845 | 0.010 |
Why?
|
Postmenopause | 1 | 2007 | 2511 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2007 | 13441 | 0.010 |
Why?
|
Energy Intake | 1 | 2003 | 2132 | 0.010 |
Why?
|
Fibroblasts | 1 | 2006 | 4137 | 0.010 |
Why?
|
Ceramides | 1 | 1996 | 200 | 0.010 |
Why?
|
Risk | 1 | 2007 | 9604 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2007 | 5110 | 0.010 |
Why?
|
United States | 3 | 2013 | 72272 | 0.010 |
Why?
|
Temperature | 1 | 1999 | 2223 | 0.010 |
Why?
|
Membrane Glycoproteins | 1 | 2002 | 3688 | 0.010 |
Why?
|
Transforming Growth Factor beta | 1 | 1999 | 1963 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2005 | 7798 | 0.010 |
Why?
|
Biopsy | 1 | 2001 | 6762 | 0.010 |
Why?
|
Health Personnel | 1 | 2003 | 3333 | 0.010 |
Why?
|
Sex Factors | 1 | 2003 | 10548 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2005 | 15251 | 0.000 |
Why?
|
Smoking | 1 | 2001 | 9050 | 0.000 |
Why?
|
Brain | 1 | 2007 | 27101 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2001 | 58894 | 0.000 |
Why?
|